Clinical Trial

To Determine Tolerability to Glucagon Infusion in Obese Subjects

Study acronym: GIO
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To further understand the tolerability of glucagon.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2016-06-24; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2017-04-24
Status change: Not Yet Recruiting → Recruiting 2017-01-09
Trial Details
NCT Number NCT02817659
Lead Sponsor AdventHealth Translational Research Institute
Conditions Obesity
Enrollment 20 participants
Start Date 2016-11-01
Primary Completion 2017-01-13 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-30